|
시장보고서
상품코드
2088226
항균 섬유 시장 : 유형별, 패브릭 유형별, 기능별, 최종사용자별, 유통 채널별 - 세계 시장 예측(2026-2032년)Antimicrobial Textiles Market by Type, Fabric Type, Functionality, End-User, Distribution Channel - Global Forecast 2026-2032 |
||||||
360iResearch
항균 섬유 시장은 2032년까지 연평균 복합 성장률(CAGR) 5.78%로 171억 4,000만 달러에 달할 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 115억 6,000만 달러 |
| 추정 연도 : 2026년 | 122억 3,000만 달러 |
| 예측 연도 : 2032년 | 171억 4,000만 달러 |
| CAGR(%) | 5.78% |
항균 섬유는 의료, 호텔·관광, 스포츠웨어, 국방, 운송, 가정용 섬유 등 다양한 분야에서 단순한 특수 가공 단계에서 전략적 소재 플랫폼으로 전환되고 있습니다. 이러한 수요는 의료 관련 감염, 항생제 내성, 악취 대책, 섬유 위생, 그리고 제품 수명 주기 연장에 대한 지속적인 우려에 힘입어 유지되고 있습니다. 이 범주에는 섬유 표면에서 세균, 곰팡이 및 기타 미생물의 증식을 억제하도록 설계된 섬유, 실, 직물, 부직포, 코팅 및 마감 처리가 포함됩니다.
가장 경쟁력 있는 항균 섬유 공급업체는 효과와 안전성, 내구성, 규정 준수, 그리고 지속가능성을 모두 충족시키고 있습니다. 구매자들은 항균성 원단을 세탁 내구성, 피부 친화성, 환경 고려 사항, 효능 입증, 그리고 ISO 20743, AATCC TM100, ASTM E2149, 관련 섬유 미생물학 프로토콜 등 공인된 시험 방법에 기반한 성능을 통해 평가하는 경향이 점점 더 강해지고 있습니다. 이에 따라 시장은 단순한 항균 기능이라는 홍보 문구에서 벗어나, 의료용 섬유, 스포츠웨어, 유니폼, 가구용 원단, 기능성 원단 등 용도별로 검증된 성능으로 점차 전환되고 있습니다.
항균 섬유 업계의 혁신적인 변화
항균 섬유 시장은 더욱 엄격해진 위생 기준에 대한 기대, 소재의 혁신, 그리고 규제 당국의 면밀한 검토에 힘입어 재편되고 있습니다. 의료 시스템, 호텔, 항공사, 대중교통 기관, 스포츠웨어 브랜드는 냄새를 줄이고, 위생 수칙을 준수하며, 반복 세탁 후에도 성능을 유지할 수 있는 섬유 소재를 찾고 있습니다. 이에 따라 의료용 침구, 수술복, 상처 주변용 소재, 재사용 가능한 마스크, 가구용 커버, 양말, 스포츠웨어 및 방호 작업복에의 적용이 확대되고 있습니다.
항균 섬유에 대한 인공지능의 누적 영향
인공지능(AI)은 배합 설계, 공정 관리, 품질 보증, 수요 계획의 개선을 통해 항균 섬유 개발을 가속화하고 있습니다. 머신러닝 모델은 항균 화학 물질의 선별, 바인더와 섬유의 적합성 예측, 코팅 부착량의 최적화, 그리고 마감 공정에서의 시행착오를 줄이는 데 도움이 됩니다. 컴퓨터 비전은 코팅된 원단의 결함 검출을 지원하며, AI를 활용한 분석을 통해 세탁 내구성, 색상 변화, 촉감, 탈취 성능 및 생산 로트 간 미생물학적 성능의 변동을 모니터링할 수 있습니다.
항균 섬유에 관한 주요 지역별 인사이트
아시아태평양은 항균 섬유 분야의 중심적인 위치를 계속해서 차지하고 있습니다. 이는 중국, 인도, 일본, 한국, 호주 및 동남아시아 국가들이 대규모 섬유 제조 생태계를 갖추고 있을 뿐만 아니라, 헬스케어, 위생, 기능성 의류에 대한 수요가 증가하고 있기 때문입니다. 이 지역은 방적, 직물, 편직, 염색, 후가공 및 의류에 이르는 통합된 공급망의 혜택을 누리고 있으며, 일본과 한국은 고성능 섬유, 나노 소재, 기능성 후가공 분야의 첨단 소재 기술 전문성을 더하고 있습니다. 인도의 테크니컬 텍스타일 정책에 대한 집중과 중국의 확립된 섬유 수출 체계는 항균 원단, 가공된 부직포 및 위생 지향적인 완제품의 보급을 더욱 촉진하고 있습니다.
항균 섬유 수요에 관한 주요 그룹 분석
아세안(ASEAN)은 제조 거점이자 수요 시장으로서 모두 중요하며, 베트남, 인도네시아, 태국, 말레이시아, 필리핀이 의류, 부직포, 의료용 소모품 및 수출 지향적인 섬유 생산을 뒷받침하고 있습니다. GCC 시장은 고급 호텔·리조트 산업, 의료 분야의 확대, 유니폼, 그리고 기후적 요인으로 인해 탈취·통기성·흡습발산성이 뛰어난 섬유에 대한 관심이 높아지면서 형성되고 있습니다. 유럽연합(EU)은 규제 준수, 제품 안전, 지속가능성 보고, 순환형 섬유 정책, 그리고 과학적 근거에 기반한 항균 효과 주장에 있어 여전히 기준이 되고 있습니다.
항균 섬유 시장의 주요 국가별 동향
미국은 의료용 섬유, 스포츠웨어, 방위용도, 시설용 섬유, 그리고 EPA(미국 환경보호청) 및 관련 규정에 근거한 제품 효능 표시를 통해 항균 섬유의 상용화를 주도하고 있습니다. 캐나다는 의료 서비스의 질, 공공 기관의 조달, 근로자 안전, 그리고 지속 가능한 섬유 기준을 중시하는 반면, 멕시코는 니어쇼어링, 의료용 제품 제조, 자동차용 섬유, 그리고 의류 무역 분야의 협력으로부터 혜택을 보고 있습니다. 브라질은 의료용 섬유, 유니폼 및 소비자용 의류를 통해 지역 경제 성장을 뒷받침하고 있으며, 영국은 의료, 기능성 섬유, 보호복 및 프리미엄 퍼포먼스 부문에서 수요를 유지하고 있습니다.
항균 섬유 업계의 리더를 위한 실천적 제안
업계 선도 기업은 광범위한 항균 홍보보다는 입증된 성능을 우선시해야 합니다. 제품 개발 팀은 상품화에 앞서 화학 조성, 기재, 최종 용도, 세탁 주기, 노출 조건 및 규제상 표시 유형을 적절히 조율해야 합니다. 의료, 의류, 가정용 또는 산업용 목적으로 사용되는 항균 섬유 제품은 출시 전에 공인된 시험 방법으로 시험을 실시하고, 내구성 데이터를 근거로 삼아 현지 규제 요건에 따라 심사를 받아야 합니다.
항균 섬유 분석을 위한 조사 기법
본 요약 보고서는 규제 지침, 섬유 시험 기준, 무역 데이터 지표, 과학 문헌, 조달 관련 자료, 의료 및 환경 당국의 정책 자료 등 검증된 공개 정보 및 업계에서 인정된 정보원을 활용한 체계적인 2차 조사 기법을 통해 작성되었습니다. 증거에 기반한 시장 성장 촉진요인, 기술 도입 패턴, 지역별 제조 강점, 최종 용도별 수요 동향, 그리고 규정 준수 관련 고려 사항에 중점을 두고 있습니다.
결론: 항균 섬유의 미래
항균 섬유 시장은 입증된 효능, 규제 준수, 내구성 및 지속가능성이 경쟁 우위를 결정짓는 더욱 엄격한 단계에 접어들고 있습니다. 의료, 스포츠웨어, 호텔·관광, 국방, 가정용 섬유, 운송 및 산업용 분야 전반에 걸쳐 수요는 여전히 견조하지만, 구매자들은 성능 주장, 세탁 내구성, 피부 안전성 및 화학 물질에 대한 투명성 측면에서 점점 더 까다롭게 선택하고 있습니다.
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향, 2026년
제7장 항균 섬유 시장 : 유형별
제8장 항균 섬유 시장 : 패브릭 유형별
제9장 항균 섬유 시장 : 기능별
제10장 항균 섬유 시장 : 최종사용자별
제11장 항균 섬유 시장 : 유통 채널별
제12장 항균 섬유 시장 : 지역별
제13장 항균 섬유 시장 : 그룹별
제14장 항균 섬유 시장 : 국가별
제15장 경쟁 구도
제16장 기업 개요
LSHThe Antimicrobial Textiles Market is projected to grow by USD 17.14 billion at a CAGR of 5.78% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 11.56 billion |
| Estimated Year [2026] | USD 12.23 billion |
| Forecast Year [2032] | USD 17.14 billion |
| CAGR (%) | 5.78% |
Antimicrobial textiles are moving from a specialty finish to a strategic material platform across healthcare, hospitality, sportswear, defense, transportation, and home textiles. Demand is supported by persistent concerns around healthcare-associated infections, antimicrobial resistance, odor control, textile hygiene, and longer product life cycles. The category includes fibers, yarns, fabrics, nonwovens, coatings, and finishes engineered to inhibit the growth of bacteria, fungi, and other microorganisms on textile surfaces.
The most competitive antimicrobial textile suppliers are aligning efficacy with safety, durability, regulatory compliance, and sustainability. Buyers increasingly evaluate antibacterial fabrics by wash durability, skin compatibility, environmental profile, claim substantiation, and performance under recognized test methods such as ISO 20743, AATCC TM100, ASTM E2149, and related textile microbiology protocols. This shifts the market from basic antimicrobial claims toward validated, application-specific performance across medical textiles, activewear, uniforms, upholstery, and technical fabrics.
Transformative Shifts in the Antimicrobial Textile Landscape
The antimicrobial textiles landscape is being reshaped by stricter hygiene expectations, material innovation, and regulatory scrutiny. Healthcare systems, hotels, airlines, public transit operators, and athletic brands are looking for textiles that reduce odor, support cleanliness protocols, and maintain performance over repeated laundering. This is driving adoption in medical bedding, scrubs, wound-adjacent materials, reusable masks, upholstery, socks, activewear, and protective workwear.
At the same time, the industry is shifting away from generic biocidal positioning toward responsible chemistry and verified durability. Silver, copper, zinc-based additives, quaternary ammonium compounds, bio-based chitosan, and other antimicrobial technologies are being assessed against durability, leaching potential, skin contact safety, antimicrobial resistance considerations, and end-of-life impacts. Brand owners are prioritizing transparent supply chains, certified inputs, and clear evidence that antimicrobial finishes remain effective without creating unacceptable environmental or compliance risk.
Cumulative Impact of Artificial Intelligence on Antimicrobial Textiles
Artificial intelligence is accelerating antimicrobial textile development by improving formulation design, process control, quality assurance, and demand planning. Machine learning models can help screen antimicrobial chemistries, predict binder-fiber compatibility, optimize coating add-on levels, and reduce trial-and-error in finishing lines. Computer vision can support defect detection in coated fabrics, while AI-enabled analytics can monitor wash durability, color change, hand feel, odor-control performance, and microbiological performance drift across production batches.
The cumulative impact is a faster path from laboratory validation to commercial scale. AI also strengthens compliance and traceability by connecting material data, supplier documentation, restricted substance screening, product stewardship records, and lifecycle indicators. For industry leaders, the strongest value comes from combining AI with verified microbiological testing, regulatory review, and human oversight so that antimicrobial textile claims remain evidence-based rather than algorithm-driven assumptions.
Key Regional Insights Across Antimicrobial Textiles
Asia-Pacific remains central to antimicrobial textiles because China, India, Japan, South Korea, Australia, and Southeast Asian economies combine large textile manufacturing ecosystems with rising demand for healthcare, hygiene, and performance apparel. The region benefits from integrated spinning, weaving, knitting, dyeing, finishing, and garment supply chains, while Japan and South Korea add advanced materials expertise in high-performance fibers, nanomaterials, and functional finishes. India's technical textile policy focus and China's established textile exports further support adoption of antibacterial fabrics, treated nonwovens, and hygiene-oriented finished goods.
North America is led by the United States and Canada, where healthcare procurement, sportswear innovation, institutional laundry, defense textiles, and regulatory oversight shape demand for antimicrobial fabrics and finished products. Latin America, led by Brazil and Mexico, shows expanding use in medical textiles, uniforms, and consumer apparel as manufacturers upgrade finishing capabilities and strengthen regional supply chains. Europe is defined by high regulatory expectations under frameworks such as the EU Biocidal Products Regulation and REACH, encouraging safer chemistries, restricted-substance compliance, and substantiated claims. The Middle East is gaining demand from hospitality, healthcare infrastructure, uniforms, and hot-climate performance apparel, while Africa presents long-term potential through healthcare textile needs, local manufacturing development, and demand for durable hygiene-focused fabrics.
Key Group Insights for Antimicrobial Textile Demand
ASEAN is important as both a manufacturing base and a demand market, with Vietnam, Indonesia, Thailand, Malaysia, and the Philippines supporting apparel, nonwovens, medical consumables, and export-oriented textile production. GCC markets are shaped by premium hospitality, healthcare expansion, uniforms, and climate-driven interest in odor-control, breathable, and moisture-management textiles. The European Union remains a benchmark for regulatory compliance, product safety, sustainability reporting, circular textile policies, and evidence-backed antimicrobial claims.
BRICS countries combine large consumer bases, textile manufacturing capacity, public-health priorities, and healthcare infrastructure needs, making them influential in both supply and demand for antimicrobial textiles. G7 markets drive premium applications, technical textiles, medical procurement standards, defense requirements, and brand-led sustainability expectations. NATO-related demand is relevant for antimicrobial uniforms, base-layer apparel, field hospitals, bedding, shelters, and protective textile systems where durability, hygiene, comfort, and performance under harsh operating conditions are essential.
Key Country Insights in the Antimicrobial Textiles Market
The United States leads in antimicrobial textile commercialization through healthcare textiles, activewear, defense applications, institutional fabrics, and regulated product claims under EPA and related frameworks. Canada emphasizes healthcare quality, institutional procurement, worker safety, and sustainable textile standards, while Mexico benefits from nearshoring, medical manufacturing, automotive textiles, and apparel trade links. Brazil supports regional growth through healthcare fabrics, uniforms, and consumer apparel, and the United Kingdom maintains demand in healthcare, technical textiles, protective clothing, and premium performance categories.
Germany, France, Italy, and Spain anchor Europe through technical textile engineering, fashion, medical textiles, public procurement, and strict chemical compliance. Russia remains relevant for uniforms, cold-weather performance materials, workwear, and industrial textiles. China is the largest manufacturing force with extensive fiber, fabric, finishing, and garment capacity; India combines scale with growing healthcare, nonwoven, and technical textile initiatives; and Japan leads in advanced fibers, precision materials, and functional textile engineering. Australia emphasizes healthcare, sportswear, mining workwear, and outdoor textiles, while South Korea contributes innovation in functional fabrics, nanotechnology, smart textiles, and export-oriented performance apparel.
Actionable Recommendations for Antimicrobial Textile Leaders
Industry leaders should prioritize verified performance over broad antimicrobial messaging. Product teams need to match chemistry, substrate, end use, wash cycle, exposure condition, and regulatory claim type before commercialization. Antimicrobial textiles intended for healthcare, apparel, home, or industrial use should be tested with recognized methods, supported by durability data, and reviewed for local regulatory requirements before launch.
Companies should also invest in safer chemistries, supplier documentation, lifecycle assessment, restricted-substance screening, and traceable manufacturing. Strategic partnerships among fiber producers, chemical suppliers, mills, test laboratories, healthcare buyers, and brand owners can reduce development risk. Commercial teams should focus on high-value applications where antimicrobial functionality solves a documented problem, including odor control, institutional hygiene, product longevity, reduced laundering burden, and performance in demanding environments.
Research Methodology for Antimicrobial Textiles Analysis
This executive summary is developed through a structured secondary-research methodology using verified public-domain and industry-recognized sources, including regulatory guidance, textile testing standards, trade data indicators, scientific literature, procurement references, and policy materials from healthcare and environmental authorities. Emphasis is placed on evidence-backed market drivers, technology adoption patterns, regional manufacturing strengths, end-use demand signals, and compliance considerations.
Insights are triangulated across end-use sectors, material technologies, regulatory frameworks, and geographic demand signals. The analysis avoids unsupported market-size, market-share, and forecasting claims and focuses on validated trends affecting antimicrobial fabrics, antibacterial finishes, treated textiles, medical textiles, nonwovens, uniforms, activewear, home textiles, and technical textiles. Findings are written for executive decision-making, discoverability, and practical industry application.
Conclusion: The Future of Antimicrobial Textiles
The antimicrobial textiles market is entering a more disciplined phase where substantiated efficacy, regulatory compliance, durability, and sustainability determine competitive advantage. Demand remains strong across healthcare, sportswear, hospitality, defense, home textiles, transportation, and industrial applications, but buyers are increasingly selective about performance claims, wash durability, skin-contact safety, and chemical transparency.
Organizations that combine advanced materials, validated testing, responsible chemistry, AI-enabled development, and regional supply-chain resilience will be best positioned to capture qualified opportunities. The future of antimicrobial textiles will favor evidence-based solutions that deliver hygiene, comfort, longevity, odor control, and trust without compromising safety, compliance, or environmental expectations.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antimicrobial Textiles Market, by Type
- 7.1. Natural Antimicrobial Textiles
- 7.1.1. Bamboo-Based Textiles
- 7.1.2. Wool-Based Textiles
- 7.1.3. Cotton-Based Textiles
- 7.2. Synthetic Antimicrobial Textiles
- 7.2.1. Polyester-Based Antimicrobial Textiles
- 7.2.2. Nylon-Based Antimicrobial Textiles
- 7.2.3. Acrylic-Based Textiles
- 7.3. Bio-Based Antimicrobial Textiles
- 7.3.1. Chitosan-Based Textiles
- 7.3.2. Herbal Extract Treated Textiles
- 7.3.3. Essential Oil Treated Textiles
8. Antimicrobial Textiles Market, by Fabric Type
- 8.1. Woven Fabrics
- 8.1.1. Plain Weave
- 8.1.2. Twill Weave
- 8.1.3. Satin Weave
- 8.2. Non-Woven Fabrics
- 8.2.1. Spunbond
- 8.2.2. Meltblown
- 8.3. Knitted Fabrics
- 8.3.1. Warp
- 8.3.2. Weft
- 8.4. Composite Fabrics
9. Antimicrobial Textiles Market, by Functionality
- 9.1. Antibacterial
- 9.2. Antifungal
- 9.3. Antiviral
10. Antimicrobial Textiles Market, by End-User
- 10.1. Healthcare
- 10.1.1. Hospital Textiles
- 10.1.1.1. Bed Sheets
- 10.1.1.2. Doctor Coats
- 10.1.1.3. Patient Gowns
- 10.1.2. Surgical Textiles
- 10.1.2.1. Surgical Drapes
- 10.1.2.2. Surgical Gowns
- 10.1.2.3. Surgical Mask Covers
- 10.1.1. Hospital Textiles
- 10.2. Hospitality
- 10.2.1. Hotel Linen
- 10.2.1.1. Bathrobes
- 10.2.1.2. Bedsheets
- 10.2.1.3. Pillow Covers
- 10.2.2. Restaurant Table Covers
- 10.2.2.1. Napkins
- 10.2.2.2. Tablecloths
- 10.2.1. Hotel Linen
- 10.3. Residential
- 10.3.1. Home Furnishings
- 10.3.1.1. Bed Linen
- 10.3.1.2. Curtains
- 10.3.1.3. Towels
- 10.3.2. Upholstery
- 10.3.2.1. Cushion Covers
- 10.3.2.2. Sofa Covers
- 10.3.1. Home Furnishings
- 10.4. Sports & Active Wear
- 10.4.1. Active Footwear
- 10.4.1.1. Running Shoes
- 10.4.1.2. Training Shoes
- 10.4.2. Sports Apparel
- 10.4.2.1. Jerseys
- 10.4.2.2. Leggings
- 10.4.2.3. Shorts
- 10.4.1. Active Footwear
11. Antimicrobial Textiles Market, by Distribution Channel
- 11.1. Offline
- 11.2. Online
12. Antimicrobial Textiles Market, by Region
- 12.1. Asia-Pacific
- 12.2. North America
- 12.3. Latin America
- 12.4. Europe
- 12.5. Middle East
- 12.6. Africa
13. Antimicrobial Textiles Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
14. Antimicrobial Textiles Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
15. Competitive Landscape
- 15.1. Market Concentration Analysis, 2025
- 15.1.1. Concentration Ratio (CR)
- 15.1.2. Herfindahl Hirschman Index (HHI)
- 15.2. Recent Developments & Impact Analysis, 2025
- 15.3. Product Portfolio Analysis, 2025
- 15.4. Benchmarking Analysis, 2025
16. Company Profiles
- 16.1. Ahlstrom Munksjo Oyj
- 16.2. Archroma Management GmbH
- 16.3. Arvind Ltd
- 16.4. Asahi Kasei Corporation
- 16.5. BASF SE
- 16.6. Biocote Limited
- 16.7. DuPont de Nemours Inc
- 16.8. HeiQ Materials AG
- 16.9. Herculite Products Inc
- 16.10. Indorama Ventures Public Company Limited
- 16.11. Kolon Industries Inc
- 16.12. Microban International Ltd
- 16.13. Milliken & Company
- 16.14. Noble Biomaterials Inc
- 16.15. Polygiene Group AB
- 16.16. Resil Chemicals Pvt Ltd
- 16.17. Rudolf GmbH
- 16.18. Sanitized AG
- 16.19. Sarex Overseas
- 16.20. Sciessent LLC
- 16.21. Smartfiber AG
- 16.22. Teijin Frontier Co Ltd
- 16.23. The Dow Chemical Company
- 16.24. Toray Industries Inc
- 16.25. Welspun Living Limited
